Opportunistic Mobile ECG Detects A-Fib in American Indians
FRIDAY, April 23, 2021 -- For American Indians, opportunistic, mobile single-lead electrocardiography (ECG) in tribal clinics can detect more cases of atrial fibrillation (AF) than usual care, according to a study published online April 21 in the Journal of the American Heart Association.
Stavros Stavrakis, M.D., Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues implemented opportunistic screening to detect silent AF in American Indians attending a tribal health system. American Indian patients aged 50 years and older underwent a 30-second ECG. All tracings were overread by a cardiologist to confirm diagnosis of AF. After diagnosis, patients were referred to their primary care physician for anticoagulation initiation. A total of 1,019 patients receiving AF screening were included and compared to 1,267 controls, seen during the same time period, who were not screened.
The researchers found that new AF was diagnosed in 1.5 percent of patients screened versus 0.3 percent of controls. Of the 15 patients with new-screen detected AF, eight were aged younger than 65 years. Compared with those without AF, patients with screen-detected AF were slightly older and had a higher CHA2DS2-VASc score. Of the 15 patients diagnosed with new AF, 14 had a CHA2DS2-VASc score ≥1 and initiated anticoagulation.
"We have a very simple and accurate method to screen and diagnose atrial fibrillation that is easy to implement at tribal clinics," Stavrakis said in a statement. "This widely-available, low-cost approach has real potential to improve health outcomes among American Indians."
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
THURSDAY, May 6, 2021 -- A deep learning model is feasible for differentiating normal or likely abnormal brain magnetic resonance imaging (MRI), according to a study published...
WEDNESDAY, May 5, 2021 -- Peloton said Wednesday it is recalling its Tread and Tread+ exercise machines, just weeks after the U.S. Consumer Product Safety Commission (CPSC) warned...
WEDNESDAY, May 5, 2021 -- For older patients with estrogen receptor (ER)-positive, clinically node-negative breast cancer, receipt of sentinel lymph node biopsy (SLNB) or adjuvant...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.